Avalyn Pharma Inc. Common Stock (AVLN) vs Harrow Health, Inc. (HROW)
A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Harrow Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVLN
Avalyn Pharma Inc. Common Stock
$25.52HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
HROW
Harrow Health, Inc.
$29.90HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
Total return — AVLN vs HROW
growth of $100 · dividends reinvested · last 1yAVLN -8.3% (-8.3%/yr)HROW -24.5% (-24.5%/yr)AVLN compounded faster over this window
AVLN HROW
AVLN vs HROW: by the numbers
- •AVLN is the larger company ($1.13B vs $1.11B market cap).
- •Both run net losses; AVLN's is the smaller (0.00% vs -13.51% net margin).
Metrics side by side
Valuation
| Metric | AVLN | HROW |
|---|---|---|
| P/S ratio | N/A | 4.04 |
| P/B ratio | 2.84 | 73.32 |
| FCF yield | N/A | 0.48% |
Profitability
| Metric | AVLN | HROW |
|---|---|---|
| Gross margin | 0.00% | 73.28% |
| Operating margin | 0.00% | 14.18% |
| Net margin | 0.00% | -13.51% |
| ROE | N/A | -244.91% |
| ROIC | -67.73% | 1.81% |
Growth (annualized)
| Metric | AVLN | HROW |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 34.52% |
| Total return CAGR (5Y) | N/A | 27.66% |
Go deeper
Dig into the metrics
Avalyn Pharma Inc. Common Stock ROEHarrow Health ROEAvalyn Pharma Inc. Common Stock operating marginHarrow Health operating marginAvalyn Pharma Inc. Common Stock revenue growthHarrow Health revenue growthAvalyn Pharma Inc. Common Stock free cash flowHarrow Health free cash flow
Avalyn Pharma Inc. Common Stock & Harrow Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.